HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission. - Wikidata - awgldk - TriplyDB

HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.

HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.

http://www.wikidata.org/entity/Q37519808

about

What is new in perinatal HIV prevention?

P2860

Q48521585-E1C8BCC6-B949-42F3-894C-5D56FBA0942E

P2860

HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.

http://www.wikidata.org/entity/Q37519808

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HIV-1 Drug Resistance by Ultra ...... Mother-to-Child Transmission.

@en

HIV-1 Drug Resistance by Ultra ...... Mother-to-Child Transmission.

@nl

type

label

HIV-1 Drug Resistance by Ultra ...... Mother-to-Child Transmission.

@en

HIV-1 Drug Resistance by Ultra ...... Mother-to-Child Transmission.

@nl

prefLabel

HIV-1 Drug Resistance by Ultra ...... Mother-to-Child Transmission.

@en

HIV-1 Drug Resistance by Ultra ...... Mother-to-Child Transmission.

@nl

P1433

Q37519808-B83515F3-3503-4315-A5D8-30C339A06A0B

P1476

Q37519808-E34E1D79-3532-4C5A-A45C-72DBAE64F922

P2093

Q37519808-319F406F-34A9-4FBE-9B16-18E18F3F2F00

Q37519808-4540566E-0784-4BF1-A9E8-8E7CCE2C5A56

Q37519808-678A84DB-BC97-45F5-97DF-C6D0D8B0287E

Q37519808-9700153B-0B6E-4A49-87E1-347FD1CCF301

Q37519808-B37EDA5C-6E10-44B8-9B23-98526E6823D0

Q37519808-C13634A9-01B1-4A9E-9AE9-76A6BD02923C

Q37519808-F1AD8118-7151-4D6C-8DE6-CE9741D2C8CE

P2860

Q37519808-021E1B78-4616-4008-8F02-9401A947B1E3

Q37519808-02C488E8-D2B3-480A-A0C5-76A55AD0B613

Q37519808-04100CB8-78A1-47D9-BCAF-08217A837E51

Q37519808-051A1EA0-4460-498C-8687-7FEC4E93B95C

Q37519808-055F5629-0068-4B63-BF2A-6346E537FBE7

Q37519808-0AE04E4E-AC8C-4949-9657-30B86F7EB830

Q37519808-0D7D16E3-E750-4261-AE64-38930E192E69

Q37519808-0EC060E8-D491-44E6-8785-CAF521C9C4B9

Q37519808-27EC7D6C-3F1A-45C7-BD9C-E6C725765A89

Q37519808-2C619169-347D-45BF-A71B-1BC0792DDCD5

P304

Q37519808-BB442CF7-B09E-4AD1-BC13-C9CEE738D376

P31

Q37519808-F06697A5-D6C7-42A4-B189-731EF572548C

P356

Q37519808-5B9920CB-BA9D-4C12-8C4A-B90D22A013C7

P407

Q37519808-1C8492CF-63F5-46C5-8991-D9B5945DA969

P433

Q37519808-CF56D6CF-414C-4706-82D0-BE106F7C1118

P478

Q37519808-50C3DE46-F8D9-44E2-A661-302A89074137

P50

Q37519808-8CDCDF10-B299-4782-84EC-B65712B10B0C

P577

Q37519808-E47AAFB6-9A4B-4175-A69F-86329A0808FD

P698

Q37519808-B3600E51-6FEB-4ED4-89CA-EE82E13DF712

P921

Q37519808-1A51049B-950E-4E6B-A3FB-1F079F0EB582

Q37519808-D6D20724-E038-48B4-B7F1-695BF5917E55

P932

Q37519808-C20F08A3-7F86-479D-9F52-10B6CD18E3EE

P356

QAI.0000000000001116

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

HIV-1 Drug Resistance by Ultra ...... Mother-to-Child Transmission.

@en

P2093

Anneta Naidoo

http://www.w3.org/2001/XMLSchema#string

Lavanya Singh

http://www.w3.org/2001/XMLSchema#string

Marc Noguera Julian

http://www.w3.org/2001/XMLSchema#string

Michelle Gordon

http://www.w3.org/2001/XMLSchema#string

Pravi Moodley

http://www.w3.org/2001/XMLSchema#string

Reshmi Samuel

http://www.w3.org/2001/XMLSchema#string

Roger Paredes

http://www.w3.org/2001/XMLSchema#string

P2860

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

Development of resistance to zidovudine in HIV strains isolated from CD4+ lymphocytes and plasma during therapy

Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort study

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation

Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens

High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.

Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.

P304

384-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0000000000001116

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Raveen Parboosing

P577

2016-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27327263

http://www.w3.org/2001/XMLSchema#string

P921

HIV transmission

prevention of HIV/AIDS

P932

5172515

http://www.w3.org/2001/XMLSchema#string